Amid NIH funding delays, clawbacks and uncertainty, a scientist at Harvard who studies breast cancer has lost one third of her lab employees and wonders if she can continue her research experiments.
Copyright 2025 NPR
Amid NIH funding delays, clawbacks and uncertainty, a scientist at Harvard who studies breast cancer has lost one third of her lab employees and wonders if she can continue her research experiments.
Copyright 2025 NPR
The biggest portion of Boise State Public Radio's funding comes from readers like you who value fact-based journalism and trustworthy information.
Your donation today helps make our local reporting free for our entire community.